5 reports of this reaction
2.4% of all ACETAMINOPHEN 325 MG reports
#9 most reported adverse reaction
PRURITUS is the #9 most commonly reported adverse reaction for ACETAMINOPHEN 325 MG, manufactured by Ulai Health LLC. There are 5 FDA adverse event reports linking ACETAMINOPHEN 325 MG to PRURITUS. This represents approximately 2.4% of all 211 adverse event reports for this drug.
Patients taking ACETAMINOPHEN 325 MG who experience pruritus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRURITUS is a less commonly reported adverse event for ACETAMINOPHEN 325 MG, but still significant enough to appear in the safety profile.
In addition to pruritus, the following adverse reactions have been reported for ACETAMINOPHEN 325 MG:
The following drugs have also been linked to pruritus in FDA adverse event reports:
PRURITUS has been reported as an adverse event in 5 FDA reports for ACETAMINOPHEN 325 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRURITUS accounts for approximately 2.4% of all adverse event reports for ACETAMINOPHEN 325 MG, making it a notable side effect.
If you experience pruritus while taking ACETAMINOPHEN 325 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.